Esophageal cancer other diagnostic studies

Revision as of 14:26, 7 December 2017 by Hadeel Maksoud (talk | contribs)
Jump to navigation Jump to search

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer other diagnostic studies

CDC on Esophageal cancer other diagnostic studies

Esophageal cancer other diagnostic studies in the news

Blogs on Esophageal cancer other diagnostic studies

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Other diagnostic studies for esophageal cancer include FDG-PET (positron emission tomography) scan and endoscopic ultrasound (EUS).

Other Diagnostic Studies

Fludeoxyglucose Positive Emission Tomography

FDG-PET (positron emission tomography) scan is also being used to estimate whether enlarged masses are metabolically active, indicating faster-growing cells that might be expected in cancer. Esophageal endoscopic ultrasound (EUS) can provide staging information regarding the level of tumor invasion, and possible spread to regional lymph nodes.[1]>[2]

Esophageal Ultrasound

EUS is the most accurate investigation for regional staging of esophageal cancer. It is capable of correctly staging T and N stagesin 90% of patients.[3]

By Samir at the English language Wikipedia, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=3231456


References

  1. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA (2013). "Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort". Ann. Oncol. 24 (5): 1262–6. doi:10.1093/annonc/mds617. PMC 3629896. PMID 23247658.
  2. Arnett AL, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL (2017). "Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation". J Thorac Oncol. 12 (1): 121–128. doi:10.1016/j.jtho.2016.08.136. PMID 27569732.
  3. Lee WC, Lee TH, Jang JY, Lee JS, Cho JY, Lee JS, Jeon SR, Kim HG, Kim JO, Cho YK (2015). "Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: is it possible?". Dis. Esophagus. 28 (6): 574–8. doi:10.1111/dote.12235. PMID 24835402.


Template:WikiDoc Sources